NanoViricides, Inc.
(NYSE Amex Equities : NNVC)

( )
NNVC After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
CELGCelgene Corporation
0.01%90.691.3%$836.99m
AMGNAmgen Inc.
0.89%188.341.2%$659.06m
GILDGilead Sciences, Inc.
1.84%67.590.9%$528.28m
BIIBBiogen Inc.
2.51%332.871.3%$459.94m
ILMNIllumina, Inc.
2.51%299.823.5%$326.05m
REGNRegeneron Pharmaceuticals, Inc.
2.17%423.972.6%$322.32m
VRTXVertex Pharmaceuticals Incorporated
1.27%188.071.9%$269.19m
ALXNAlexion Pharmaceuticals, Inc.
2.77%129.422.0%$243.58m
AAgilent Technologies, Inc.
1.64%78.281.6%$138.30m
INCYIncyte Corporation
0.88%84.152.5%$117.93m
ALNYAlnylam Pharmaceuticals, Inc
0.60%83.539.2%$73.46m
SGENSeattle Genetics, Inc.
4.24%71.486.6%$70.53m
BLUEBluebird Bio, Inc.
2.04%137.0314.4%$66.91m
NKTRNektar Therapeutics
-2.18%41.695.5%$59.28m
MGNXMacroGenics, Inc.
3.41%21.847.2%$57.08m

Company Profile

NanoViricides, Inc. is a development stage company, which engages in the development of nanomedicine drugs against viruses. It focuses on anti-viral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs. The company was founded by Anil R. Diwan on July 25, 2000 and is headquartered in Shelton, CT.